DETECTION AND MANAGEMENT OF CHRONIC DISEASE REINVENTED
Leveraging advanced analytics and biomonitoring for early detection and diagnostic and treatment guidance to preempt the advance of disease
Approximately $850 billion or 80% of health care costs per year are due to the treatment of chronic disease. Rather than emphasizing the efficient management of patients with established disease, HealthReveal’s mission is to preempt the transition from being at risk for disease to the emergence of disease, yielding an unprecedented opportunity to reduce health care costs and give people longer, healthier lives.
Our cloud-based, digital health solution is analyzing in real time the health of at-risk patients and intervening with evidence-based diagnostic and treatment guidance. Through continuous monitoring, health risks are detected and proactively addressed to avoid costly utilization and permanent adverse health outcomes.
An essential part of our mission is engaging patients in their care through biomonitoring, dynamic communication with their care team and providing financial incentives for adherence.
We are enabling the alignment of delivery system partners in value-based care arrangements. Our approach extends beyond traditional risk bearers such as purchasers, payers, providers and Accountable Care Organizations and includes patients, pharmaceutical companies and device manufacturers.